Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Obesity: HELP
Saswata Talukdar
Based on 9 articles published since 2010
(Why 9 articles?)
||||
Expertise Level
The expertise of Saswata Talukdar ranks in the
  • Top 1.6%
  • ... of 283,502 published authors worldwide on Obesity
  • ... from 2010 through 2020
  • ... based on contributions to 9 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    Merck and Co      
2020
  • Atkins Center of Excellence in Obesity Medicine, Center for Human Nutrition, John T. Milliken Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. · Department of Nutritional Sciences and Toxicology, College of Natural Resources, University of California at Berkeley, Berkeley, California, USA. · Liver Imaging Group, University of California, San Diego, La Jolla, California, USA. · Merck & Co., San Francisco, California, USA. · Pubmed 31805015
2017
  • Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, L8N 3Z5, Canada. · Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Denmark. · Liver Disease Research, Takeda Pharmaceuticals, 35 Landsdowne Street, Cambridge, MA, 02139, USA. · Cardiovascular & Metabolic Diseases, Novartis Institute of Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA. · Wayne State University School of Medicine, Detroit, MI, 48201, USA. · Cardiometabolic Diseases, Merck Research Laboratories South San Francisco LLC, 630 Gateway Boulevard, South San Francisco, CA, 94080, USA. · Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main St. W., Hamilton, Ontario, L8N 3Z5, Canada. · Pubmed 28580278
2016
  • Pfizer Inc, 610 Main Street, South Bldg, 4th Floor, Cambridge, MA, 02139, USA. · , 4916 Olde Millcrest Court, Raleigh, NC, 27609, USA. · Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA, 02115, USA. · Pfizer Inc, 610 Main Street, South Bldg, 4th Floor, Cambridge, MA, 02139, USA. · Pubmed 27405817
Probable:    Pfizer      
2017
  • Pfizer Inc., Cambridge, Massachusetts, USA. · Pfizer Inc., Groton, Connecticut, USA. · Pubmed 28573777
2016
  • Cardiovascular Metabolic and Endocrine Disease Research Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139, USA. Electronic address: · Cardiovascular Metabolic and Endocrine Disease Research Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139, USA. · Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139, USA. · Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. · Drug Safety Research and Development, Pfizer Inc., Groton, CT 06340, USA. · Cardiovascular Metabolic and Endocrine Disease Research Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139, USA. Electronic address: · Pubmed 26959184
  • Pfizer Inc, 610 Main Street, South Bldg, 4th Floor, Cambridge, MA, 02139, USA. · , 4916 Olde Millcrest Court, Raleigh, NC, 27609, USA. · Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA, 02115, USA. · Pfizer Inc, 610 Main Street, South Bldg, 4th Floor, Cambridge, MA, 02139, USA. · Pubmed 27405817
2015
  • Cardiovascular Metabolic and Endocrine Diseases (CVMED) Pfizer, Inc. 610 Main Street, Cambridge, MA 02139, USA. · 1] Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA [2] CovX Research, Pfizer WRD, USA. · Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. · CovX Research, Pfizer WRD, USA. · Pubmed 26153793
  • Cardiovascular Metabolic and Endocrine Diseases (CVMED) Research Unit, Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts, 02139, United States of America; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts, 02139, United States of America. · Cardiovascular Metabolic and Endocrine Diseases (CVMED) Research Unit, Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts, 02139, United States of America. · Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts, 02139, United States of America. · Pubmed 25790234
2014
  • Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America. · Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America; Clinical and Experimental Endocrinology, Catholic University Leuven, Leuven, Belgium. · Pfizer Inc. Research Laboratories, Cambridge, Massachusetts, United States of America. · Department of Orthopedic Surgery, University of California San Diego, La Jolla, California, United States of America. · Pubmed 25244011
Probable:    University of California San Diego   Contact    
2015
  • Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, USA, 92093. · Pubmed 25706874
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Saswata Talukdar in 2010-2020 about Obesity:

  • Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. 2020
  • FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis. 2017
  • Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates. 2017
  • A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. 2016
  • PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates. 2016
  • FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance. 2015
  • Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice. 2015
  • LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. 2015
  • Knock-down of IL-1Ra in obese mice decreases liver inflammation and improves insulin sensitivity. 2014
Show List of Full Article Records
Google Searches

Learn more about Saswata Talukdar using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Merck and Co
Pfizer
University of California San Diego
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Merck and Co
2020
  • Atkins Center of Excellence in Obesity Medicine, Center for Human Nutrition, John T. Milliken Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. · Department of Nutritional Sciences and Toxicology, College of Natural Resources, University of California at Berkeley, Berkeley, California, USA. · Liver Imaging Group, University of California, San Diego, La Jolla, California, USA. · Merck & Co., San Francisco, California, USA. · Pubmed 31805015
2017
  • Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, L8N 3Z5, Canada. · Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Denmark. · Liver Disease Research, Takeda Pharmaceuticals, 35 Landsdowne Street, Cambridge, MA, 02139, USA. · Cardiovascular & Metabolic Diseases, Novartis Institute of Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA. · Wayne State University School of Medicine, Detroit, MI, 48201, USA. · Cardiometabolic Diseases, Merck Research Laboratories South San Francisco LLC, 630 Gateway Boulevard, South San Francisco, CA, 94080, USA. · Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main St. W., Hamilton, Ontario, L8N 3Z5, Canada. · Pubmed 28580278
2016
  • Pfizer Inc, 610 Main Street, South Bldg, 4th Floor, Cambridge, MA, 02139, USA. · , 4916 Olde Millcrest Court, Raleigh, NC, 27609, USA. · Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA, 02115, USA. · Pfizer Inc, 610 Main Street, South Bldg, 4th Floor, Cambridge, MA, 02139, USA. · Pubmed 27405817
Pfizer
2017
  • Pfizer Inc., Cambridge, Massachusetts, USA. · Pfizer Inc., Groton, Connecticut, USA. · Pubmed 28573777
2016
  • Cardiovascular Metabolic and Endocrine Disease Research Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139, USA. Electronic address: · Cardiovascular Metabolic and Endocrine Disease Research Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139, USA. · Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139, USA. · Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. · Drug Safety Research and Development, Pfizer Inc., Groton, CT 06340, USA. · Cardiovascular Metabolic and Endocrine Disease Research Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139, USA. Electronic address: · Pubmed 26959184
  • Pfizer Inc, 610 Main Street, South Bldg, 4th Floor, Cambridge, MA, 02139, USA. · , 4916 Olde Millcrest Court, Raleigh, NC, 27609, USA. · Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA, 02115, USA. · Pfizer Inc, 610 Main Street, South Bldg, 4th Floor, Cambridge, MA, 02139, USA. · Pubmed 27405817
2015
  • Cardiovascular Metabolic and Endocrine Diseases (CVMED) Pfizer, Inc. 610 Main Street, Cambridge, MA 02139, USA. · 1] Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA [2] CovX Research, Pfizer WRD, USA. · Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. · CovX Research, Pfizer WRD, USA. · Pubmed 26153793
  • Cardiovascular Metabolic and Endocrine Diseases (CVMED) Research Unit, Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts, 02139, United States of America; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts, 02139, United States of America. · Cardiovascular Metabolic and Endocrine Diseases (CVMED) Research Unit, Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts, 02139, United States of America. · Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, Massachusetts, 02139, United States of America. · Pubmed 25790234
2014
  • Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America. · Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America; Clinical and Experimental Endocrinology, Catholic University Leuven, Leuven, Belgium. · Pfizer Inc. Research Laboratories, Cambridge, Massachusetts, United States of America. · Department of Orthopedic Surgery, University of California San Diego, La Jolla, California, United States of America. · Pubmed 25244011
University of California San Diego
2015
  • Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, USA, 92093. · Pubmed 25706874
Yearly article counts 10022310000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.